Overview
Alseres Pharmaceuticals is committed to improving clinical outcomes and quality of life for people living with devastating traumatic injuries or degenerative conditions.
Our product candidates are designed to diagnose or treat traumatic injuries, alleviate painful, debilitating symptoms, and enable patients to live more fulfilling lives.
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|
 |
|||||||
| CNS | |||||||
| Cethrin® | Acute spinal cord injury | ||||||
| Inosine | SCI, TBI, Stroke | ||||||
| ALSE-100, etal. | Chronic SCI, TBI | ||||||
| OCULAR | |||||||
| Oncomodulin | Optic Nerve Injury/ Glaucoma |
||||||
| ALSE-100 | Glaucoma/macular degeneration/ retinis pigmentosa |
||||||
| BONE | |||||||
| ALSE-100 | Bone repair/ osteo-induction |
||||||
| OTHER | |||||||
| ALSE-100, etal. | Cardiomyopathy/ Oncology |
||||||
 |
|||||||
| ALTROPANE® | Parkinson's Disease | ||||||
| ALTROPANE® | Dementia with Lewy Bodies (DLB) | ||||||
| Tc-based agents | Parkinson's Disease | ||||||
| Tc-based agents | DLB/ADHD | ||||||
 |
|||||||
| DAT Blocker | Parkinson's Disease | ||||||
For more information on a particular product candidate or indication, please click on the corresponding product name in the chart above.